Home

Headache

Depression, Schizophrenia

Treating comorbidity of depression and anxiety and addressing side effects of some medications

At ECNP 2021, Professor Roger McIntyre chatted with us about anxiety in people with major...

Read time: 3 min

Congress highlights

Is highly potent cannabis driving first episode psychosis?

Regular use of potent cannabis is strongly linked to the incidence of psychosis, according to...

Read time: 5 min

Optimising clinical management in generalised anxiety disorder

Generalised anxiety disorder (GAD) is characterised by excessive, out of proportion, hard to...

Read time: 2 min

Congress highlights

Inflammation and glutamate dysregulation: unravelling the aetiology of schizophrenia

Reduced glutamatergic signalling and immune dysregulation are two major aetiological hypotheses in...

Depression, Schizophrenia

World Mental Health Day and the burgeoning role of digital technology

At ECNP 2021, Professor Roger McIntyre highlighted the importance of World Mental Health Day...

Read time: 3 min

Congress highlights

Debate continues over long-term antipsychotic use

Care in choice of agent, caution in efforts to discontinue therapy and the need for more studies...

Measuring patient life engagement in schizophrenia in clinical trials and clinical practice

Professor Andrea Fagiolini sat down with us at ECNP 2021 to discuss how patient life engagement in...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Who might benefit most from a personalized treatment plan to support brain health?

Individuals vary in their resilience or vulnerability to Alzheimer’s disease, said Professor...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country